PTA Balloon Catheter Market Size & Share 2024 - 2032

PTA Balloon Catheter Market Size

PTA Balloon Catheters Market size was valued at around USD 2.2 billion in 2023 and is expected to reach around USD 4.4 billion by 2032 at a CAGR of 8.1% during the forecast period. The increasing prevalence of urological and cardiovascular diseases coupled with improved diagnostic techniques are attributed to be the primary growth factors propelling the market growth.

 There is a growing burden of cardiovascular complications among survivors of urological cancers, indicating a need for increased awareness and management strategies to address the cardiovascular health of these patients. For instance, urinary tract infections (UTIs), being the most common urological disorder, accounted for 8.6 million ambulatory care visits in the U.S. according to the data reported by Centers for Disease control and Prevalence (CDC).

Additionally, the CDC reported 695,000 deaths due to heart disease and 375,476 deaths due to coronary arterial disease in the U.S. in 2021. Thus, due to the increased prevalence of such diseases, the demand for PTA balloon catheters is anticipated to rise throughout the analysis period. A PTA (Percutaneous Transluminal Angioplasty) balloon catheter is a medical device used in interventional radiology and cardiology procedures to treat narrowed or blocked blood vessels, typically arteries.
 

PTA Balloon Catheter Market Trends

The increasing awareness and improved diagnostic methods for cardiovascular diseases have significantly contributed to the market growth. As more people become aware of the risk factors and symptoms associated with cardiovascular diseases, there is an increased demand for effective diagnostic tools and treatment option.
 

• Increasing emphasis on preventive healthcare encourages individuals to undergo routine health screenings and assessments, including vascular evaluations. As more people become proactive about their health, there is a greater demand for diagnostic tests and treatments like PTA balloon angioplasty to address vascular issues before they escalate into more serious conditions.
   
• Additionally, advanced diagnostic methods such as angiography, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and intravascular ultrasound (IVUS) enable healthcare professionals to accurately detect and diagnose vascular diseases at earlier stages. This early detection allows for timely interventions, including PTA balloon angioplasty, which can prevent disease progression and improve patient outcomes.
   

PTA Balloon Catheter Market Analysis

Based on material type, the market is segmented into polyurethane, nylon, and other material types. The nylon segment held leading revenue share in 2023 and is anticipated to reach over USD 2.2 billion by 2032.
 

• Nylon balloons offer robust advantages such as high tensile strength, flexibility, and better balloon inflation properties. These characteristics make nylon catheters suitable for navigating through tortuous vessels and performing angioplasty procedures effectively.  
   
• Moreover, the shift towards minimally invasive procedures continues to grow due to benefits such as reduced recovery times, shorter hospital stays, and lower risks of complications. Nylon balloon catheters are essential components in these procedures, thereby, driving the product demand.
   

Based on type, the PTA balloon catheter market is segmented into standard PTA balloon catheters and specialty PTA balloon catheters. The standard PTA balloon catheters segment is anticipated to reach USD 2.9 billion by 2032.
 

• Standard PTA balloon catheters are designed to address a broad range of arterial blockages across different anatomical locations, including coronary and peripheral arteries. Their versatility allows them to be used in various interventional procedures, making them more widely applicable and demandable.
   
• Moreover, standard PTA balloon catheters are often more cost-effective, making them a preferred choice in healthcare settings where cost considerations play a significant role in decision-making. The lower cost of standard catheters can lead to higher utilization rates and market growth.  
   

Based on application, the PTA balloon catheter market is segmented into peripheral artery disease and coronary artery disease. The peripheral artery disease segment held leading revenue share and was valued at USD 1.4 billion in 2023.
 

• The increasing prevalence of PAD, driven by factors such as aging populations, sedentary lifestyles, and the prevalence of risk factors such as diabetes and hypertension, has led to a higher demand for interventions to treat arterial blockages associated with PAD.
   
• Moreover, PTA balloon catheters are now used to treat a wide range of peripheral arterial lesions beyond the traditional indications, including complex lesions, calcified lesions, and chronic total occlusions. This expanded indication spectrum has broadened the applicability of PTA balloon catheters for PAD interventions.

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the PTA balloon catheter market is segmented into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment held leading revenue share of around 53.8% in 2023 and is anticipated to witness healthy growth over the forecast period.
 

• Hospitals employ skilled healthcare professionals, including interventional cardiologists, interventional radiologists, vascular surgeons, and specialized nursing staff, who are trained and experienced in performing PTA balloon catheterization procedures. This enables the hospital facilities to remain the primary end-users of PTA balloon catheters, thus, fueling the market growth. 
   
• Moreover, hospitals typically have access to reimbursement mechanisms and funding sources that support the provision of medical services, including PTA balloon catheterization procedures. Proper availability of reimbursement services ensures that hospitals can sustainably deliver high-quality care to patients requiring vascular interventions.

North America PTA balloon catheter market accounted for around USD 678.9 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America has well-developed healthcare infrastructure and reimbursement policies that support the provision of advanced medical interventions, including PTA balloon catheterization. Favorable reimbursement policies incentivize healthcare providers to perform these procedures, ensuring patient access to appropriate treatment services thus, increasing the demand for PTA balloon catheter in the region.
   
• Furthermore, North America has a relatively high healthcare expenditure per capita compared to other regions, enabling patients to access advanced medical technologies and treatments. The availability of resources and funding supports the utilization of PTA balloon catheters in the management of cardiovascular diseases.
   

PTA Balloon Catheter Market Share

The competitive landscape of the PTA (Percutaneous Transluminal Angioplasty) balloon catheter industry is dynamic and comprises several key players, including established medical device companies, emerging startups, and regional manufacturers. Launching new products with improved and enhanced features is among the key market strategy by industry players.
 

PTA Balloon Catheter Market Companies

Some of the eminent market participants operating in the PTA balloon catheter industry include:

• Abbott Laboratories
• Boston Scientific Corporation
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Cook Medical
• Biotronik
• AndraTec
• Surmodics, Inc.
• Cardinal Health
• Medtronic plc
• Natec Medical Ltd.
• Terumo Corporation
   

PTA Balloon Catheter Industry News:

• In December 2022, Boston Scientific Corporation announced that it would buy a partial stake in Acotec Scientific Holdings Ltd., a Chinese medical technology company, valued at around USD 523 million. This strategic development enabled the company to improve its product portfolio and industry position in various therapeutic areas, including cardiology and neurology.
   
• In May 2022, Medtronic announced that it has received the U.S. FDA approval for its product IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. It is indicated for the treatment of peripheral artery disease. This development will enhance company's product portfolio and improve its business prospects.
   

PTA balloon catheter market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Material Type

• Polyurethane
• Nylon
• Other material types

Market, By Type

• Standard PTA balloon catheters
• Specialty PTA balloon catheters

Market, By Application

• Peripheral artery disease
• Coronary artery disease

Market, By End-use

• Hospital
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa